(Q48248991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Nicolas Aide

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

6

Dimitris Visvikis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Mohamed Majdoub

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Brice Lavigne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pascal Do

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jeannick Madelaine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mathieu Hatt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

21 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

2324-2335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-016-3441-2

14 March 2020

exact match

0 references

cites work

Standards for PET image acquisition and quantitative data analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Methodological aspects of multicenter studies with quantitative PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Fully 3-D PET reconstruction with system matrix derived from point source measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

The age of reason for FDG PET image-derived indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Image-derived biomarkers and multimodal imaging strategies for lung cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

PET functional volume delineation: a robustness and repeatability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Autoclustering of Non-small Cell Lung Carcinoma Subtypes on (18)F-FDG PET Using Texture Analysis: A Preliminary Result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

Mutatis Mutandis: Harmonize the Standard!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3441-2

High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27325312

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27325312

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-016-3441-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325312%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference